Alkermes plc Enterprise value
What is the Enterprise value of Alkermes plc?
The Enterprise value of Alkermes plc is $4.07B
What is the definition of Enterprise value?
Enterprise value is a measure of a company’s total market value. It is calculated as market capitalization with debt, minority interest, and preferred shares minus total cash and cash equivalents.
ttm (trailing twelve months)
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Enterprise value of companies in the Health Care sector on NASDAQ compared to Alkermes plc
What does Alkermes plc do?
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Companies with enterprise value similar to Alkermes plc
- Datto has Enterprise value of $4.06B
- Realogy Corp has Enterprise value of $4.06B
- Sotera Health Co has Enterprise value of $4.06B
- Ingenia Communities Stapled Units has Enterprise value of $4.07B
- Ströer SE & Co. KGaA has Enterprise value of $4.07B
- VERBIO Vereinigte BioEnergie AG has Enterprise value of $4.07B
- Alkermes plc has Enterprise value of $4.07B
- GRENKE AG has Enterprise value of $4.07B
- Saracen Mineral has Enterprise value of $4.07B
- Five Below Inc has Enterprise value of $4.07B
- ATOS SE has Enterprise value of $4.08B
- Atos SE has Enterprise value of $4.08B
- Array Technologies has Enterprise value of $4.08B